Prostate Cancer
2018 Prostate Cancer Research Highlights
- Combining Metformin with Androgen Deprivation Therapy to Treat Advanced Prostate Cancer
- Clinical Implications for Long Non-coding RNAs in Prostate Cancer
- CDK12 loss is a distinct immunogenic class of advanced prostate cancer
- Autonomic Nerves Drive Prostate Cancer Growth, Invasion, and Metastasis
- Inhibition of ACK1 to Overcome Drug Resistance in Prostate Cancer
- Chimeric Amino Acid Rearrangements as Immune Targets in Prostate Cancer
- Noninvasive Detection of AR-FL/AR-V7 as a Predictive Biomarker for Therapeutic Resistance in Men with Metastatic Castration-Resistant Prostate Cancer
- Circulating tumor cell analysis as a treatment-specific biomarker for prostate cancer
- Targeting the Aberrant Androgen Receptor in Advanced Treatment-Resistant Prostate Cancer
Last updated Thursday, May 26, 2022